01:46 PM EST, 11/24/2025 (MT Newswires) -- Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund (XLV) adding 0.7%.

The iShares Biotechnology ETF (IBB) gained 1%.

In corporate news, Eli Lilly ( LLY ) is benefiting from the "broadening" GLP-1 market for obesity and type-2 diabetes, Morgan Stanley said. The brokerage said in a note that the glucagon-like peptide-1, or GLP-1, market will continue to grow for both obesity and type-2 diabetes. Morgan Stanley raised the stock's price target to $1,290 from $1,171, while keeping the company's overweight rating. Eli Lilly ( LLY ) shares were up 0.4%.

Novo Nordisk ( NVO ) shares fell 5.5% after it said that Alzheimer's trials using semaglutide failed to show a slowdown in disease progression.

GE HealthCare Technologies ( GEHC ) shares rose 2.5% after it said Monday it has submitted a 510(k) application to the US Food and Drug Administration for Photonova Spectra, a photon-counting computed tomography system.

Biogen (BIIB) shares added 1.5% after the company and Dayra Therapeutics said they have launched a collaboration to research and develop oral macrocyclic peptides for priority targets in immunological conditions.